MENU
+Compare
ARDX
Stock ticker: NASDAQ
AS OF
Jan 30 closing price
Price
$5.36
Change
-$0.12 (-2.19%)
Capitalization
1.3B

ARDX Ardelyx Forecast, Technical & Fundamental Analysis

a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases

Industry Biotechnology
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ARDX with price predictions
Jan 29, 2025

Aroon Indicator for ARDX shows an upward move is likely

ARDX's Aroon Indicator triggered a bullish signal on January 24, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 192 similar instances where the Aroon Indicator showed a similar pattern. In of the 192 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where ARDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARDX just turned positive on January 23, 2025. Looking at past instances where ARDX's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

ARDX moved above its 50-day moving average on January 23, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ARDX crossed bullishly above the 50-day moving average on January 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARDX advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ARDX as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ARDX broke above its upper Bollinger Band on January 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.019) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). ARDX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (4.980) is also within normal values, averaging (276.027).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ARDX is expected to report earnings to rise ∞% to 0 cents per share on March 05

Ardelyx ARDX Stock Earnings Reports
Q4'24
Est.
$0.01
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.03
Q4'23
Missed
by $0.03
The last earnings report on October 31 showed earnings per share of 0 cents, beating the estimate of -5 cents. With 3.64M shares outstanding, the current market capitalization sits at 1.30B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWGIX61.440.10
+0.16%
American Century Growth I
CGTRX10.440.01
+0.10%
Columbia Select Large Cap Growth Inst2
EDIRX10.64N/A
N/A
Eaton Vance Global Income Builder R
KBIWX10.70N/A
N/A
KBI Global Investors Aquarius Instl
TQCRX18.61N/A
N/A
Touchstone Dividend Equity R6

ARDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-2.19%
VCYT - ARDX
45%
Loosely correlated
+3.83%
HRTX - ARDX
41%
Loosely correlated
+3.59%
XENE - ARDX
35%
Loosely correlated
+0.70%
PCVX - ARDX
35%
Loosely correlated
+3.70%
PTGX - ARDX
34%
Loosely correlated
+2.38%
More